Correlation Between Miromatrix Medical and Monopar Therapeutics
Can any of the company-specific risk be diversified away by investing in both Miromatrix Medical and Monopar Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Miromatrix Medical and Monopar Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Miromatrix Medical and Monopar Therapeutics, you can compare the effects of market volatilities on Miromatrix Medical and Monopar Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Miromatrix Medical with a short position of Monopar Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Miromatrix Medical and Monopar Therapeutics.
Diversification Opportunities for Miromatrix Medical and Monopar Therapeutics
0.77 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Miromatrix and Monopar is 0.77. Overlapping area represents the amount of risk that can be diversified away by holding Miromatrix Medical and Monopar Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Monopar Therapeutics and Miromatrix Medical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Miromatrix Medical are associated (or correlated) with Monopar Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Monopar Therapeutics has no effect on the direction of Miromatrix Medical i.e., Miromatrix Medical and Monopar Therapeutics go up and down completely randomly.
Pair Corralation between Miromatrix Medical and Monopar Therapeutics
Given the investment horizon of 90 days Miromatrix Medical is expected to under-perform the Monopar Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Miromatrix Medical is 4.18 times less risky than Monopar Therapeutics. The stock trades about -0.05 of its potential returns per unit of risk. The Monopar Therapeutics is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest 1,340 in Monopar Therapeutics on August 26, 2024 and sell it today you would earn a total of 670.00 from holding Monopar Therapeutics or generate 50.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 31.99% |
| Values | Daily Returns |
Miromatrix Medical vs. Monopar Therapeutics
Performance |
| Timeline |
| Miromatrix Medical |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Monopar Therapeutics |
Miromatrix Medical and Monopar Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Miromatrix Medical and Monopar Therapeutics
The main advantage of trading using opposite Miromatrix Medical and Monopar Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Miromatrix Medical position performs unexpectedly, Monopar Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Monopar Therapeutics will offset losses from the drop in Monopar Therapeutics' long position.| Miromatrix Medical vs. Anebulo Pharmaceuticals | Miromatrix Medical vs. Pmv Pharmaceuticals | Miromatrix Medical vs. Bionomics Ltd ADR | Miromatrix Medical vs. Molecular Partners AG |
| Monopar Therapeutics vs. Eliem Therapeutics | Monopar Therapeutics vs. HCW Biologics | Monopar Therapeutics vs. Scpharmaceuticals | Monopar Therapeutics vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Other Complementary Tools
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device |